{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:06:48Z","timestamp":1789247208263,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"CDC\u2019s","award":["PS19-1901"],"award-info":[{"award-number":["PS19-1901"]}]},{"name":"CDC\u2019s","award":["CK19-1904"],"award-info":[{"award-number":["CK19-1904"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>California has experienced an increase in reported cases of disseminated gonococcal infection (DGI). Given significant morbidity associated with DGI and the ability of Neisseria gonorrhoeae to rapidly develop antibiotic resistance, characterization of these cases can inform diagnosis, management, and prevention of DGI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>As part of the public health response to increased reports of DGI, we used gonorrhea surveillance data reported to the California Department of Public Health to identify all DGI cases in a geographically-bound region. Standardized case report forms were used to collect epidemiologic risk factors and clinical information obtained from provider\/laboratory reports, medical records, and patient interviews.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From 1 July 2020 to 31 July 2021, we identified 149 DGI patients among 63 338 total gonorrhea infections, representing 0.24% of gonorrhea cases. Estimated incidence was 0.47 DGI cases per 100 000 person-years. Mean age of DGI patients was 40 years, and 75 (50%) were cisgender men, of whom only 13 were known to have male partners. Where reported, more than one-third (36%) used methamphetamine and nearly one-quarter (23%) experienced homelessness. Clinically, 61% lacked urogenital, pharyngeal, or rectal symptoms; 2 patients died in the hospital. Among 47 isolates from patients with antimicrobial susceptibility testing (AST) results available, all were susceptible to ceftriaxone and cefixime.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Most DGI patients lacked urogenital symptoms and were not among populations for which routine gonorrhea screening is currently recommended. Expanding gonorrhea screening might prevent DGI. Cefixime is likely the best option if transitioning from parenteral to oral therapy when AST results are unavailable.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciac805","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T12:33:09Z","timestamp":1664800389000},"page":"194-200","source":"Crossref","is-referenced-by-count":29,"title":["Characterizing the Rise of Disseminated Gonococcal Infections in California, July 2020\u2013July 2021"],"prefix":"10.1093","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-7708","authenticated-orcid":false,"given":"Eric C","family":"Tang","sequence":"first","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A","family":"Johnson","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"},{"name":"Division of Infectious Diseases, Department of Medicine, University of California , San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizzete","family":"Alvarado","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole O","family":"Burghardt","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Lopez","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazima","family":"Jenkins-Barnes","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Hughes","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krysta L","family":"Salas","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen R","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Sexually Transmitted Diseases Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health , Richmond, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"2023011318302977800_ciac805-B1","author":"Centers for Disease Control and Prevention"},{"key":"2023011318302977800_ciac805-B2","first-page":"627","volume-title":"Sexually transmitted diseases","author":"Hook","year":"2008","edition":"4th ed"},{"key":"2023011318302977800_ciac805-B3","first-page":"1259","volume-title":"Sexually transmitted diseases","author":"Rice","year":"2008","edition":"4th ed"},{"key":"2023011318302977800_ciac805-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2023011318302977800_ciac805-B5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/cid\/ciac052","article-title":"Surveillance for disseminated gonococcal infections, active bacterial core surveillance (ABCs)\u2014United States, 2015\u20132019","volume":"75","author":"Weston","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023011318302977800_ciac805-B6","author":"California Department of Public Health"},{"key":"2023011318302977800_ciac805-B7","author":"California Department of Public Health"},{"key":"2023011318302977800_ciac805-B8","author":"California Department of Public Health"},{"key":"2023011318302977800_ciac805-B9","author":"California Department of Public Health"},{"key":"2023011318302977800_ciac805-B10","author":"California Department of Public Health"},{"key":"2023011318302977800_ciac805-B11","author":"Centers for Disease Control and Prevention"},{"key":"2023011318302977800_ciac805-B12","author":"California Department of Finance"},{"key":"2023011318302977800_ciac805-B13","volume-title":"Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100","author":"Clinical Laboratory Standards Institute","year":"2020"},{"key":"2023011318302977800_ciac805-B14","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"2023011318302977800_ciac805-B15","author":"U.S. Food and Drug Administration"},{"key":"2023011318302977800_ciac805-B16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-74-6-979","article-title":"Disseminated gonococcal infection","volume":"74","author":"Holmes","year":"1971","journal-title":"Ann Intern Med"},{"key":"2023011318302977800_ciac805-B17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005792-198311000-00005","article-title":"Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms","volume":"62","author":"O\u2019Brien","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"2023011318302977800_ciac805-B18","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1001\/archinte.1994.00420230077009","article-title":"Gonococcal arthritis in an era of increasing penicillin resistance: presentations and outcomes in 41 recent cases (1985\u20131991)","volume":"154","author":"Wise","year":"1994","journal-title":"Arch Intern Med"},{"key":"2023011318302977800_ciac805-B19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/AOG.0b013e318244eda9","article-title":"Disseminated gonococcal infection in women","volume":"119","author":"Bleich","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2023011318302977800_ciac805-B20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-90-6-917","article-title":"Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency","volume":"90","author":"Petersen","year":"1979","journal-title":"Ann Intern Med"},{"key":"2023011318302977800_ciac805-B21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/cid\/ciy958","article-title":"Disseminated gonococcal infections in patients receiving eculizumab: a case series","volume":"69","author":"Crew","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023011318302977800_ciac805-B22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.15585\/mmwr.mm6912a5","article-title":"Notes from the field: ongoing cluster of highly related disseminated gonococcal infections\u2014southwest Michigan, 2019","volume":"69","author":"Nettleton","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023011318302977800_ciac805-B23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jama.2021.10577","article-title":"Screening for chlamydial and gonococcal infections: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"Cantor","year":"2021","journal-title":"JAMA"},{"key":"2023011318302977800_ciac805-B24","doi-asserted-by":"crossref","first-page":"1900147","DOI":"10.2807\/1560-7917.ES.2019.24.10.1900147","article-title":"Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018","volume":"24","author":"Eyre","year":"2019","journal-title":"Euro Surveill"},{"key":"2023011318302977800_ciac805-B25","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.15585\/mmwr.mm6949a5","article-title":"Notes from the field: first case in the United States of Neisseria gonorrhoeae harboring emerging mosaic pena60 allele, conferring reduced susceptibility to cefixime and ceftriaxone","volume":"69","author":"Picker","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023011318302977800_ciac805-B26","author":"Centers for Disease Control and Prevention"},{"key":"2023011318302977800_ciac805-B27","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med"},{"key":"2023011318302977800_ciac805-B28","author":"California Department of Public Health"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac805\/46698855\/ciac805.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/2\/194\/48710334\/ciac805.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/2\/194\/48710334\/ciac805.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T01:53:56Z","timestamp":1673661236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/2\/194\/6746983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,10,3]]},"published-print":{"date-parts":[[2023,1,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac805","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,15]]},"published":{"date-parts":[[2022,10,3]]}}}